Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Slides:

Advertisements

Similar presentations

Chronic Lyme Disease: A Survey of Connecticut Primary Care Physicians Michael Johnson, MD, Henry M. Feder, MD The Journal of Pediatrics Volume 157, Issue.

Advertisements

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Preoperative Evaluations: The Very Last Chance To Identify a Problem With a Pacemaker or Implanted Cardioverter-Defibrillator Marc A. Rozner, PhD, MD Journal.

The additional hospital costs generated in the management of complications of pacemaker and defibrillator implantations T.Bruce Ferguson, MD, Candice Lilley.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

The Rise of Renal Pathology in Nephrology: Structure Illuminates Function Vivette D. D'Agati, MD, Michael Mengel, MD American Journal of Kidney Diseases.

Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Variation in Use of Dual-Chamber Implantable Cardioverter-Defibrillators:

Rationale, design, and baseline characteristics of the Canagliflozin Cardiovascular Assessment Study (CANVAS)—A randomized placebo-controlled trial Bruce.

An Early Look at Performance on the Emergency Care Measures Included in Medicare's Hospital Inpatient Value-Based Purchasing Program Megan McHugh, PhD,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST) Kirsten E. Fleischmann,

Downstream coronary effects of drug-eluting stents

Tell-tale Telangiectasias

Overview of the 2012 Food and Drug Administration Circulatory System Devices Panel of the Medical Devices Advisory Committee meeting on the Edwards SAPIEN.

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.

Colloquium on Therapy of Right Heart Failure

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation Jan-Malte Sinning, MD, Martin Horack, MS, Eberhard.

American Heart Journal

Severe Tuberculosis Sepsis in an Immunocompetent Patient

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics Cheryl Bushnell,

CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy.

Neutral impact on systolic and diastolic cardiac function of 2 years of intensified multi- intervention in type 2 diabetes: The randomized controlled Asker.

Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Anh L. Bui, MD, Maria.

Air Pollution and Chest Disease

Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice Manesh R.

Manuel J. Antunes, MD, PhD, DSc

Pneumothorax Recurrence Related to High-speed Lift

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance Judith.

Roy D. Ayalon, MD, Frederick Friedman, MD

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective.

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

An Unusual Cause of Leg Ulcerations

James M. Beattie, MBChB, FRCP, James N. Kirkpatrick, MD, Kristen K

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Incidence and Mortality Rates of Syncope in the United States

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Andre J. Gauri, MD, Andrew Davis, MD, Thomas Hong, MD, Martin C

The Reply The American Journal of Medicine

Intrinsic cardiac stem cells are essential for regeneration

Form ever follows function

William M. DeCampli, MD, PhD

Volume 11, Issue 2, Pages (February 2014)

Ethnic and racial disparities in cardiac resynchronization therapy

A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients Khanh Nguyen, MD The Journal.

Transvenous versus transthoracic cardioverter-defibrillator implantation: A comparative analysis of morbidity, mortality, and survival David M. Shahian,

Volume 12, Issue 10, Pages (October 2015)

Insomnia in the Elderly: Cause, Approach, and Treatment

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Sutureless valve implantation: Every detail counts

The ascent of POEM: Double-tunnel per oral endoscopic re-myotomy

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Hope should not spring eternal

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Falls in Older Adults: Risk Assessment, Management and Prevention

Out of sight, out of mind Dawn S. Hui, MD, Richard Lee, MD, MBA

Apples remain apples NO matter what

The treatment of patients with infected implantable cardioverter-defibrillator systems Sean O'Nunain, MB, Irving Perez, MD, Marc Roelke, MD, Stefan Osswald,

Longer Lengths of Stay and Higher Risk of Mortality among Inpatients of Physicians with More Years in Practice William N. Southern, MD, MS, Eran Y. Bellin,

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

Lessons learned from Melody valve retrieved at transplantation

Presentation transcript:

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry Rachel Lampert, MD, Yongfei Wang, MS, Jeptha P. Curtis, MD American Heart Journal Volume 165, Issue 6, Pages 1015-1023.e2 (June 2013) DOI: 10.1016/j.ahj.2012.12.003 Copyright © 2013 Mosby, Inc. Terms and Conditions

Figure 1 Timeline depicting model families available at the start of the analysis period and those released during the analysis period. American Heart Journal 2013 165, 1015-1023.e2DOI: (10.1016/j.ahj.2012.12.003) Copyright © 2013 Mosby, Inc. Terms and Conditions

Figure 2 Hospital variation in use of “previously released” devices. American Heart Journal 2013 165, 1015-1023.e2DOI: (10.1016/j.ahj.2012.12.003) Copyright © 2013 Mosby, Inc. Terms and Conditions

Figure 3 Physician variation in use of previously released devices. American Heart Journal 2013 165, 1015-1023.e2DOI: (10.1016/j.ahj.2012.12.003) Copyright © 2013 Mosby, Inc. Terms and Conditions

Figure 4 Correlation of physician use of “previously released” devices between hospitals. Each point represents the correlation between hospitals for 1 physician of the 174 physicians performing at least 10 implants at each of 2 hospitals. R2 value for the correlation was 0.25, P < .001. American Heart Journal 2013 165, 1015-1023.e2DOI: (10.1016/j.ahj.2012.12.003) Copyright © 2013 Mosby, Inc. Terms and Conditions